Letters to the Editor
Controlled clinical trials: the current ethical debate From Dr G I M Swyer London NW3 Sir, In his thought-provoking -and disturbingeditorial (February Journal, p 85), Professor Duncan Vere refers to 'a crucial aspect of the argument which recurs throughout the debate. A doctrine seems to have arisen ... that people can be blamed for having made false decisions in the light of evidence which is shown subsequently to have been inadequate but where new evidence accrued because they decided as they did. In short, they decided upon a trial which elicits new facts, which in turn reveal that they were mistaken in those beliefs which seemed to necessitate a trial'. The doctrine of retrospective blame, he concludes, is pernicious. The doctrine in fact opposes the very basis on which scientific method depends -the experimental rejection of inappropriate hypotheses. That it should be lawyers and journalists who espouse such a cause need give little surprise, but it is vexatious that their misguided endeavours should trouble scientists and doctors.
Later, Professor Vere refers to the argument that 'trials are unethical'. He disagrees, of course. He might have added that failure to make a valid trial could itself be unethical. I recollect a time when a famous endocrinologist, who might have been expected to know better, rejected the idea of a controlled trial of progesterone implantation treatment for recurrent abortion on the grounds that he would have considered it unethical to withhold this treatment from any of his appropriate patients. No one now regards that treatment as effective -it merely exposes the patient to minor inconvenience and the risk of local infection, both at unnecessary expense. Of course, when a hitherto 100%fatal disease such as tuberculous meningitis responds to treatment with streptomycin, no one proposes a controlled trial; but how often does that situation arise? And how often have ineffective treatments, with their own adverse effects, continued to be prescribed because controlled trials have not been undertaken! A suggested alternative which, as Professor Vere points out, has already been adopted in the laws of some European countries, is to abandon trials as a necessary test criterion for all remedies and to rely on expert opinion. Shades of Hilaire Belloc! Oh! let us never, never doubt What nobody is sure about! I have taken a few examples of distortion from the many quoted in Professor Vere's editorial which reflects the Byzantine argument of those who, despite their lack of training in or experience of scientific method and medical practice, believe themselves to be qualified by their own, quite different training, to comment disparagingly on what has, in fact, been one of the intellectually most praiseworthy developments in scientific medicine and one, incidentally; in which this country has played a leading role. It is, as I have said, a pity that those engaged in these praiseworthy endeavours should have to adopt a defensive stance against pernicious and retrogressive attacks.
Yours faithfully G I M SWYER 18 February 1981
From Dr John Bishop Harman London WI Dear Sir, May I add a comment to Professor Vere's comprehensive editorial (February Journal. p 85) on the ethics of clinical trials? The profession seems to be agreed that experiments on humans are of two kinds, each with different ethical obligations. They are the therapeutic experiment where the subject is a patient receiving treatment, and the non-therapeutic where the subject is a guinea-pig with no hope of benefit. Unfortunately the public, which includes the Pearson Commission, has been so impressed by the experimental element in a clinical trial that it has overlooked the therapeutic. Subjects in a trial receive treatment and the benefit that is hoped for is not made less because the doctors take special care to assess the results. Further, it is not realized how large a part trial and error play in the ordinary treatment of patients. If this could be accepted by the public, the position would be simpler. The relationship between experimenter and subject in a clinical trial would then be the same as between doctor and patient. in clinical practice, which is well enough understood. The ethics of non-therapeutic experiments are quite a different matter. Yours faithfully J B HARMAN 24 February 1981 
